| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
2006 ABS Annual Meeting Index
|
|
|
2006
|
5 |
2 |
p. 137-138
2 p.
|
artikel
|
| 2 |
Accuracy of DVH calculation in modern brachytherapy treatment planning systems
|
Kirisits, Christian
|
|
2006
|
5 |
2 |
p. 97-98
2 p.
|
artikel
|
| 3 |
Accuracy of postimplant seed reconstruction studied with a CT- and MRI-compatible prostate phantom
|
De Brabandere, Marisol
|
|
2006
|
5 |
2 |
p. 96-
1 p.
|
artikel
|
| 4 |
Acute effects of partial breast brachytherapy using the MammoSite catheter vs whole breast external beam radiotherapy: Experience in a community hospital
|
Koprowski, Christopher D.
|
|
2006
|
5 |
2 |
p. 88-
1 p.
|
artikel
|
| 5 |
American Brachytherapy Society 2006 Annual Meeting Program
|
|
|
2006
|
5 |
2 |
p. 63-69
7 p.
|
artikel
|
| 6 |
A multi-institutional Phase II trial for Cesium-131 permanent prostate brachytherapy
|
Prestidge, Bradley
|
|
2006
|
5 |
2 |
p. 79-
1 p.
|
artikel
|
| 7 |
An analysis of simulation for adjuvant intracavitary high-dose-rate brachytherapy in early stage endometrial cancer
|
Barney, Brandon M.
|
|
2006
|
5 |
2 |
p. 102-
1 p.
|
artikel
|
| 8 |
Androgen deprivation therapy does not impact cause-specific or overall survival following permanent prostate brachytherapy
|
Merrick, Gregory S.
|
|
2006
|
5 |
2 |
p. 86-
1 p.
|
artikel
|
| 9 |
Androgen replacement therapy for hypogonadism after brachytherapy for prostate cancer
|
Sarosdy, Michael F.
|
|
2006
|
5 |
2 |
p. 106-107
2 p.
|
artikel
|
| 10 |
A pilot study assessing the use of a novel LDR intracavitary brachytherapy applicator for carcinoma of the cervix uteri
|
Elsayyad, Nagy
|
|
2006
|
5 |
2 |
p. 99-
1 p.
|
artikel
|
| 11 |
A quality of life (QOL) assessment of prostate cancer patients undergoing different radiation treatment modalities
|
Saputo, K.
|
|
2006
|
5 |
2 |
p. 92-
1 p.
|
artikel
|
| 12 |
A quantitative analysis of dose reductions due to a radiopaque iodine-based contrast solution in Ir-192 HDR MammoSite balloon: Monte Carlo calculations, TLD, MOSFET and ion-chamber measurements
|
Parsai, E. Ishmael
|
|
2006
|
5 |
2 |
p. 94-
1 p.
|
artikel
|
| 13 |
Brachytherapy in men ≤54 years of age with clinically localized prostate cancer
|
Merrick, Gregory S.
|
|
2006
|
5 |
2 |
p. 107-
1 p.
|
artikel
|
| 14 |
Can intraoperative inverse planning predict rectal dose in permanent seed implants of the prostate?
|
Bujold, Alexis
|
|
2006
|
5 |
2 |
p. 106-
1 p.
|
artikel
|
| 15 |
Cholangiocarcinoma: The impact of endobiliary high-dose-rate (HDR) brachytherapy dose response on survival
|
Biagioli, Matthew
|
|
2006
|
5 |
2 |
p. 91-
1 p.
|
artikel
|
| 16 |
Clinical benefits of a class solution for inversely planned high-dose-rate prostate brachytherapy
|
Lessard, Etienne
|
|
2006
|
5 |
2 |
p. 96-97
2 p.
|
artikel
|
| 17 |
Clinical results of HDR Pd-103 brachytherapy for wet age-related macular degeneration
|
Rivard, Mark J.
|
|
2006
|
5 |
2 |
p. 98-
1 p.
|
artikel
|
| 18 |
Commentary on “Medical malpractice in the age of technology: How specialty societies can make a difference (Anscher and Anscher)”
|
Wallner, Kent E.
|
|
2006
|
5 |
2 |
p. 135-136
2 p.
|
artikel
|
| 19 |
Comparative analysis of CT-based 3D volumetric dosimetry and radiography-based 2D dosimetry for high-dose-rate intracavitary applications
|
Patil, Nikhilesh G.
|
|
2006
|
5 |
2 |
p. 99-
1 p.
|
artikel
|
| 20 |
Comparison of 2D vs. 3D dosimetry for Rotte ‘Y’ applicator high-dose-rate brachytherapy for medically inoperable endometrial cancer
|
Beriwal, Sushil
|
|
2006
|
5 |
2 |
p. 100-
1 p.
|
artikel
|
| 21 |
Comparison of inverse planning simulated annealing and graphical optimization for prostate high dose-rate brachytherapy
|
Sankreacha, Raxa
|
|
2006
|
5 |
2 |
p. 84-85
2 p.
|
artikel
|
| 22 |
Correlation of dose volume parameters, rectoscopy findings and rectal side effects in cervix cancer patients treated with definitive radiotherapy including MRI-based brachytherapy
|
Georg, Petra
|
|
2006
|
5 |
2 |
p. 81-
1 p.
|
artikel
|
| 23 |
3D Analysis of dose to the bladder, sigmoid, and rectum in vaginal cylinder brachytherapy
|
Holloway, Caroline L.
|
|
2006
|
5 |
2 |
p. 102-
1 p.
|
artikel
|
| 24 |
4D CT dosimetric analysis of the Mayo Clinic brachytherapy technique for a cholangiocarcinoma patient
|
Furutani, Keith M.
|
|
2006
|
5 |
2 |
p. 84-
1 p.
|
artikel
|
| 25 |
3D dosimetric comparison of two CT-compatible applicators: Tandem and ring and tandem and ovoids applicator
|
Hsu, I-Chow J.
|
|
2006
|
5 |
2 |
p. 101-
1 p.
|
artikel
|
| 26 |
Decreased intra-fraction prostate motion post permanent implant relative to non-implant patients
|
McLaughlin, Patrick W.
|
|
2006
|
5 |
2 |
p. 80-
1 p.
|
artikel
|
| 27 |
Dermatological applications of HDR using surface applicators using a shorter treatment schedule
|
Amendola, Beatriz E.
|
|
2006
|
5 |
2 |
p. 106-
1 p.
|
artikel
|
| 28 |
Dose perturbation in the presence of vaginal cylinder with Ir-192 HDR source: A radiochromic film dosimetry study
|
Chiu-Tsao, Sou-Tung
|
|
2006
|
5 |
2 |
p. 97-
1 p.
|
artikel
|
| 29 |
Dose selection of resin 90Y-microspheres for liver brachytherapy: A single center review
|
Kennedy, Andrew S.
|
|
2006
|
5 |
2 |
p. 103-104
2 p.
|
artikel
|
| 30 |
Dose to rectum, small bowel, and sacrum using CT-based planning for vaginal cuff HDR brachytherapy
|
Bui, C.
|
|
2006
|
5 |
2 |
p. 103-
1 p.
|
artikel
|
| 31 |
Dose volume relations in HR-CTV as predictive factors for local tumor control in MRI-based cervical cancer brachytherapy: Comparison between patients with and without recurrence
|
Dimopoulos, Johannes
|
|
2006
|
5 |
2 |
p. 81-
1 p.
|
artikel
|
| 32 |
Dosimetric study of an intracavitary mold applicator for high-dose-rate rectal brachytherapy treatment
|
Poon, Emily
|
|
2006
|
5 |
2 |
p. 83-
1 p.
|
artikel
|
| 33 |
Dosimetric variations between subsequent cervic cancer brachytherapy insertions: Can we use only one MRI-based treatment plan?
|
Kirisits, Christian
|
|
2006
|
5 |
2 |
p. 81-82
2 p.
|
artikel
|
| 34 |
DVH analysis and quality assurance of high-dose-rate (HDR) brachytherapy for prostate cancer
|
Nair, Murali
|
|
2006
|
5 |
2 |
p. 96-
1 p.
|
artikel
|
| 35 |
Effect of dose prescription on HDR vaginal brachytherapy
|
Li, Shidong
|
|
2006
|
5 |
2 |
p. 82-
1 p.
|
artikel
|
| 36 |
Efficacy of neoadjuvant bicalutamide and dutasteride as a cytoreductive regimen prior to prostate brachytherapy
|
Merrick, Gregory S.
|
|
2006
|
5 |
2 |
p. 108-
1 p.
|
artikel
|
| 37 |
External beam radiotherapy in comparison to brachytherapy in the prevention of restenosis after femoropopliteal artery angioplasty
|
Donath, David
|
|
2006
|
5 |
2 |
p. 79-80
2 p.
|
artikel
|
| 38 |
Extracapsular radiation dose annulus correlates with biochemical control in low-risk brachytherapy patients: Results of a prospective randomized trial
|
Merrick, Gregory S.
|
|
2006
|
5 |
2 |
p. 78-
1 p.
|
artikel
|
| 39 |
False positive rate of the ASTRO and Houston biochemical failure definitions in a group of prostate brachytherapy patients with a five-year minimum followup
|
Ciezki, Jay P.
|
|
2006
|
5 |
2 |
p. 108-117
10 p.
|
artikel
|
| 40 |
Flattering filter design for HDR surface applicators
|
Ballester, Facundo
|
|
2006
|
5 |
2 |
p. 98-
1 p.
|
artikel
|
| 41 |
Fractionation, dose selection, and response of hepatic metastases of neuroendocrine tumors after 90Y-microsphere brachytherapy
|
Kennedy, Andrew S.
|
|
2006
|
5 |
2 |
p. 103-
1 p.
|
artikel
|
| 42 |
GliaSite radiotherapy boost as part of initial treatment of malignant gliomas: A multi-institutional analysis
|
Welsh, James
|
|
2006
|
5 |
2 |
p. 78-79
2 p.
|
artikel
|
| 43 |
Guide for Authors
|
|
|
2006
|
5 |
2 |
p. A6-
1 p.
|
artikel
|
| 44 |
HDR brachytherapy in carcinoma cervix: Rectal retractor or gauze packing?
|
Patil, Nikhilesh G.
|
|
2006
|
5 |
2 |
p. 82-
1 p.
|
artikel
|
| 45 |
HDR inverse planning using differential evolution
|
Silvern, David A.
|
|
2006
|
5 |
2 |
p. 85-
1 p.
|
artikel
|
| 46 |
HI-ART tomotherapy megavoltage CT-based cumulative dose volume histograms and isodose curve plans for low-dose-rate brachytherapy of cervical cancer
|
Boyd, Jessamy A.
|
|
2006
|
5 |
2 |
p. 101-
1 p.
|
artikel
|
| 47 |
High-dose-rate (HDR) brachytherapy with surface applicators–treatment for nonmelanomatous skin cancer
|
Musmacher, Jeffrey S.
|
|
2006
|
5 |
2 |
p. 105-
1 p.
|
artikel
|
| 48 |
Hypogonadism is more common than expected in men about to undergo prostate brachytherapy, independent of age and degree of erectile dysfunction
|
Sarosdy, Michael F.
|
|
2006
|
5 |
2 |
p. 107-
1 p.
|
artikel
|
| 49 |
ICRU points significantly underestimate the bladder and rectal dose delivered by high-dose-rate brachytherapy for cervical cancer
|
Shah, Shalin
|
|
2006
|
5 |
2 |
p. 100-101
2 p.
|
artikel
|
| 50 |
ICRU reference points underestimate rectal and bladder doses in interstitial HDR brachytherapy of locally advanced cervix cancer
|
Yaparpalvi, Ravindra
|
|
2006
|
5 |
2 |
p. 99-100
2 p.
|
artikel
|
| 51 |
Image-guided interstitial brachytherapy of lung tumors
|
O'Connor, Brigid
|
|
2006
|
5 |
2 |
p. 105-
1 p.
|
artikel
|
| 52 |
Image-guided 125I prostate brachytherapy in a community setting: Five-year results
|
Shanahan, Thomas G.
|
|
2006
|
5 |
2 |
p. 108-
1 p.
|
artikel
|
| 53 |
Initial cosmesis and toxicity results with high-dose-rate intracavitary brachytherapy for early stage breast cancer
|
Husain, Zain A.
|
|
2006
|
5 |
2 |
p. 95-
1 p.
|
artikel
|
| 54 |
Interim report of a permanent breast 103Pd seed implant (PBSI) Phase I/II trial for accelerated partial breast irradiation
|
Pignol, Jean-Philippe
|
|
2006
|
5 |
2 |
p. 89-
1 p.
|
artikel
|
| 55 |
Interstitial high-dose-rate (HDR) brachytherapy as monotherapy for early stage prostate cancer
|
Mark, Rufus J.
|
|
2006
|
5 |
2 |
p. 90-
1 p.
|
artikel
|
| 56 |
Interstitial high-dose-rate (HDR) brachytherapy for early stage breast cancer
|
Mark, Rufus J.
|
|
2006
|
5 |
2 |
p. 87-88
2 p.
|
artikel
|
| 57 |
Interstitial high-dose-rate (HDR) brachytherapy+IMRT vs. HDR monotherapy for early stage prostate cancer
|
Mark, Rufus
|
|
2006
|
5 |
2 |
p. 108-
1 p.
|
artikel
|
| 58 |
Interstitial high-dose-rate (HDR) brachytherapy under local anesthesia for early stage prostate cancer
|
Mark, Rufus J.
|
|
2006
|
5 |
2 |
p. 106-
1 p.
|
artikel
|
| 59 |
Interstitial implant alone with or without external beam radiation therapy for intermediate risk localized prostate cancer: Patterns of Care Study in the United States
|
Frank, Steven J.
|
|
2006
|
5 |
2 |
p. 92-
1 p.
|
artikel
|
| 60 |
Intraoperative prostate brachytherapy: does real-time ultrasound-based dosimetry obviate the need for post implant dosimetry analysis? A retrospective analysis of 1,000 patients treated at Kaiser Permanente
|
Mahmoudieh, Alireza
|
|
2006
|
5 |
2 |
p. 80-
1 p.
|
artikel
|
| 61 |
Intraoperative radiation therapy for breast cancer: Early cosmetic results
|
Beal, Kathryn
|
|
2006
|
5 |
2 |
p. 88-89
2 p.
|
artikel
|
| 62 |
Intraoperative radiotherapy with HDR brachytherapy or electron beam for advancedgynecologic malignancies
|
Nag, Subir
|
|
2006
|
5 |
2 |
p. 100-
1 p.
|
artikel
|
| 63 |
In vivo MOSFET detector used in the post-operative dose assessment of I-125 prostate implants
|
Jurkovic, Ines
|
|
2006
|
5 |
2 |
p. 97-
1 p.
|
artikel
|
| 64 |
LDR brachytherapy implants as a boost in early stage breast cancer in women with cilastic implants
|
Do, Ly
|
|
2006
|
5 |
2 |
p. 95-
1 p.
|
artikel
|
| 65 |
Listing of Oral and Poster Presentations of the 27th Annual Meeting of the American Brachytherapy Society
|
|
|
2006
|
5 |
2 |
p. 70-77
8 p.
|
artikel
|
| 66 |
Long-term outcome and toxicity in a Phase I/II trial using HDR multicatheter interstitial brachytherapy for T1-2 breast cancer
|
Kaufman, Seth A.
|
|
2006
|
5 |
2 |
p. 86-
1 p.
|
artikel
|
| 67 |
Mammographic surveillance after MammoSite breast brachytherapy: Analysis of architectural patterns and additional interventions
|
Dragun, Anthony E.
|
|
2006
|
5 |
2 |
p. 93-
1 p.
|
artikel
|
| 68 |
MammoSite catheter HDR brachytherapy for patients who refuse mastectomy for localized breast cancer after prior radiation
|
Sawhney, Amrita G.
|
|
2006
|
5 |
2 |
p. 94-
1 p.
|
artikel
|
| 69 |
Masthead
|
|
|
2006
|
5 |
2 |
p. A1-
1 p.
|
artikel
|
| 70 |
Medical malpractice in the age of technology: How specialty societies can make a difference
|
Anscher, Mitchell S.
|
|
2006
|
5 |
2 |
p. 131-134
4 p.
|
artikel
|
| 71 |
Megavoltage cone-beam CT to complement CT-based treatment planning for HDR brachytherapy
|
Descovich, Martina
|
|
2006
|
5 |
2 |
p. 85-86
2 p.
|
artikel
|
| 72 |
Migration of prostate brachytherapy seeds to the vertebral venous plexus
|
Nakano, Masahiro
|
|
2006
|
5 |
2 |
p. 127-130
4 p.
|
artikel
|
| 73 |
Multi-catheter versus balloon breast brachytherapy: Is one method dosimetrically superior?
|
Patel, Rakesh R.
|
|
2006
|
5 |
2 |
p. 89-
1 p.
|
artikel
|
| 74 |
Organ preservation using interstitial radiation therapy for base of tongue cancer: University of Cincinnati experience
|
Mierzwa, Michelle L.
|
|
2006
|
5 |
2 |
p. 104-
1 p.
|
artikel
|
| 75 |
Partial wedge resection and LDR I-125 permanent implant brachytherapy: A 3D analysis
|
Chan, Michael D.
|
|
2006
|
5 |
2 |
p. 104-105
2 p.
|
artikel
|
| 76 |
Persistent seroma after intraoperative placement of MammoSite for APBI: Incidence, pathological anatomy, and contributing factors
|
Evans, Suzanne B.
|
|
2006
|
5 |
2 |
p. 87-
1 p.
|
artikel
|
| 77 |
Pilot study evaluating early tolerance in patients undergoing accelerated partial breast irradiation (APBI) treated with MammoSite® using a two-day dose schedule
|
Wallace, Michelle
|
|
2006
|
5 |
2 |
p. 88-
1 p.
|
artikel
|
| 78 |
Preliminary analysis of the ProQura multi-institutional prostate brachytherapy dosimetry database
|
Grimm, Peter D.
|
|
2006
|
5 |
2 |
p. 91-
1 p.
|
artikel
|
| 79 |
Pretreatment PSA velocity is associated with freedom from biochemical recurrence of prostate cancer following low-dose-rate prostate brachytherapy alone
|
Rossi, Peter J.
|
|
2006
|
5 |
2 |
p. 79-
1 p.
|
artikel
|
| 80 |
Progress on the supplement to the 2004 update of the AAPM Task Group No. 43 Report
|
Rivard, Mark J.
|
|
2006
|
5 |
2 |
p. 84-
1 p.
|
artikel
|
| 81 |
PSA bounce after permanent implant prostate brachytherapy may mimic a biochemical failure: A study of 295 patients with a minimum 3-year followup
|
Toledano, Alain
|
|
2006
|
5 |
2 |
p. 122-126
5 p.
|
artikel
|
| 82 |
Publishing Info
|
|
|
2006
|
5 |
2 |
p. A2-
1 p.
|
artikel
|
| 83 |
Quality assurance of seed implants using CT/MRI phantoms
|
Siebert, Frank-Andre
|
|
2006
|
5 |
2 |
p. 85-
1 p.
|
artikel
|
| 84 |
Quality of life (qQOL), patient satisfaction and cosmesis following partial breast irradiation (PBRT) with balloon brachytherapy
|
Albuquerque, Kevin
|
|
2006
|
5 |
2 |
p. 93-94
2 p.
|
artikel
|
| 85 |
Radiation dose to the internal pudendal arteries from permanent seed prostate brachytherapy as determined by time-of-flight angiography
|
Crook, Juanita
|
|
2006
|
5 |
2 |
p. 78-
1 p.
|
artikel
|
| 86 |
Re-irradiation with temporary Iridium-192 high-dose-rate prostate brachytherapy for recurrent prostate cancer patients who failed external beam radiation therapy and/or prostate seed brachytherapy
|
Tena, Lawrence B.
|
|
2006
|
5 |
2 |
p. 92-93
2 p.
|
artikel
|
| 87 |
Results of primary treatment of small or medium sized uveal melanoma with custom-made Nag Iodine-125 eye plaque: The Ohio State University experience with 119 patients
|
El-Ghamry, Moataz N.
|
|
2006
|
5 |
2 |
p. 90-
1 p.
|
artikel
|
| 88 |
Retrospective evaluation of single treatment plan per course vs plan per fraction for high-dose-rate vaginal cylinders
|
Nixon, Earl
|
|
2006
|
5 |
2 |
p. 102-
1 p.
|
artikel
|
| 89 |
Table of Contents
|
|
|
2006
|
5 |
2 |
p. A5-
1 p.
|
artikel
|
| 90 |
Temporal relationship between colorectal cancer and clinically localized prostate cancer in patients managed with permanent interstitial brachytherapy
|
Gutman, Sarah
|
|
2006
|
5 |
2 |
p. 93-
1 p.
|
artikel
|
| 91 |
The meaning of prescription dose and D90 in permanent seed prostate brachytherapy
|
Butler, Wayne M.
|
|
2006
|
5 |
2 |
p. 87-
1 p.
|
artikel
|
| 92 |
The predicted effect of HDR dose heterogeneity on local/regional control for post-surgical patients: Location matters
|
Deasy, Joseph O.
|
|
2006
|
5 |
2 |
p. 105-
1 p.
|
artikel
|
| 93 |
The prognostic value of percent positive biopsies in intermediate to high risk prostate cancer treated with brachytherapy and supplemental beam radiotherapy
|
Nurani, Rizwan D.
|
|
2006
|
5 |
2 |
p. 89-90
2 p.
|
artikel
|
| 94 |
The use of ultrasound for post implant dosimetric analysis of prostate seed implants
|
Goodgame, James R.
|
|
2006
|
5 |
2 |
p. 98-
1 p.
|
artikel
|
| 95 |
Three-dimensional dosimetry and Q/A in multi-catheter APBI
|
Zoberi, Imran
|
|
2006
|
5 |
2 |
p. 94-95
2 p.
|
artikel
|
| 96 |
Total scalp and other circumferential large surface area mold irradiation technique for skin lesions using multi-catheter HDR brachytherapy
|
Holmes, Timothy
|
|
2006
|
5 |
2 |
p. 104-
1 p.
|
artikel
|
| 97 |
Towards HDR 252Cf brachytherapy: Shielding assessment of a linear accelerator vault
|
Melhus, Christopher S.
|
|
2006
|
5 |
2 |
p. 83-84
2 p.
|
artikel
|
| 98 |
Toxicity from bowel perforation in interstitial implants for treatment of cancers of the gynecological tract
|
Elnaggar, Mini J.
|
|
2006
|
5 |
2 |
p. 83-
1 p.
|
artikel
|
| 99 |
Transperineal implantation of hyaluronic acid in the anterior peri-rectal fat as protector to the rectal wall from radiation delivered with either intensity modulated brachytherapy or EBRT for prostate cancer patients
|
Prada, Pedro
|
|
2006
|
5 |
2 |
p. 91-
1 p.
|
artikel
|
| 100 |
Treatment of early breast cancer using MammoSite in a community-based practice with emphasis on patients' acceptance
|
Amendola, Beatriz E.
|
|
2006
|
5 |
2 |
p. 95-
1 p.
|
artikel
|
| 101 |
Twice-daily high-dose-rate brachytherapy for medically inoperable uterine cancer
|
Gerszten, Kristina
|
|
2006
|
5 |
2 |
p. 118-121
4 p.
|
artikel
|
| 102 |
Vaginal dose delivered by tandem and ovoid versus tandem and ring in cervical cancer
|
Holloway, Caroline L.
|
|
2006
|
5 |
2 |
p. 82-
1 p.
|
artikel
|
| 103 |
Verification of treatment times for tandem and ring HDR brachytherapy
|
Daesi, Pushkar T.
|
|
2006
|
5 |
2 |
p. 101-102
2 p.
|
artikel
|
| 104 |
Vienna experience in 145 cervical cancer patients treated by systematic MRI-based intracavitary±interstitial brachytherapy from 1998-2003: Impact on local control
|
Potter, Richard
|
|
2006
|
5 |
2 |
p. 86-87
2 p.
|
artikel
|
| 105 |
Whole pelvis radiation therapy followed by brachytherapy boost with Iodine-125 or Palladium-103 versus definitive brachytherapy with Iodine-125 or Palladium-103: Late radiation morbidity profile
|
McGann, Camille F.
|
|
2006
|
5 |
2 |
p. 107-108
2 p.
|
artikel
|
Tijdschrift beschrijving